A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma

Background: Here, we establish a prognostic signature based on glycosyltransferase-related genes (GTRGs) for head and neck squamous cell carcinoma (HNSCC) patients.Methods: The prognostic signature of GTRGs was constructed via univariate and multivariate Cox analyses after obtaining the expression p...

Full description

Bibliographic Details
Main Authors: Huili Wu, Xiao Zhao, Tingting Zhu, Di Rong, Ying Wang, Diya Leng, Daming Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.856671/full
_version_ 1811323489847607296
author Huili Wu
Huili Wu
Huili Wu
Huili Wu
Xiao Zhao
Xiao Zhao
Xiao Zhao
Xiao Zhao
Tingting Zhu
Tingting Zhu
Tingting Zhu
Tingting Zhu
Di Rong
Di Rong
Di Rong
Di Rong
Ying Wang
Ying Wang
Ying Wang
Ying Wang
Diya Leng
Diya Leng
Diya Leng
Diya Leng
Daming Wu
Daming Wu
Daming Wu
Daming Wu
author_facet Huili Wu
Huili Wu
Huili Wu
Huili Wu
Xiao Zhao
Xiao Zhao
Xiao Zhao
Xiao Zhao
Tingting Zhu
Tingting Zhu
Tingting Zhu
Tingting Zhu
Di Rong
Di Rong
Di Rong
Di Rong
Ying Wang
Ying Wang
Ying Wang
Ying Wang
Diya Leng
Diya Leng
Diya Leng
Diya Leng
Daming Wu
Daming Wu
Daming Wu
Daming Wu
author_sort Huili Wu
collection DOAJ
description Background: Here, we establish a prognostic signature based on glycosyltransferase-related genes (GTRGs) for head and neck squamous cell carcinoma (HNSCC) patients.Methods: The prognostic signature of GTRGs was constructed via univariate and multivariate Cox analyses after obtaining the expression patterns of GTRGs from the TCGA. A nomogram based on the signature and clinical parameters was established to predict the survival of each HNSCC patient. Potential mechanisms were explored through gene set enrichment analysis (GSEA) and immune cell infiltration, immune checkpoints, immunotherapy, and tumor mutational burden (TMB) analyses. The expression differences and prognostic efficacy of the signature were verified through the gene expression omnibus (GEO) and several online databases.Results: The prognostic signature was constructed based on five glycosyltransferases (PYGL, ALG3, EXT2, FUT2, and KDELC1) and validated in the GSE65858 dataset. The pathways enriched in the high- and low-risk groups were significantly different. The high-risk group had higher tumor purity; lower infiltration of immune cells, such as CD8+ T cells and Tregs; higher cancer-associated fibroblast (CAF) infiltration; lower immune function; and lower checkpoint expression. The signature can also be applied to distinguish whether patients benefit from immunotherapy. In addition, the high-risk group had a higher TMB and more gene mutations, including those in TP53, CSMD1, CDKN2A, and MUC17.Conclusion: We propose a prognostic signature based on glycosyltransferases for HNSCC patients that may provide potential targets and biomarkers for the precise treatment of HNSCC.
first_indexed 2024-04-13T13:56:05Z
format Article
id doaj.art-fb06aa6cf9c44de5a78ddca1a233abe7
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-04-13T13:56:05Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-fb06aa6cf9c44de5a78ddca1a233abe72022-12-22T02:44:12ZengFrontiers Media S.A.Frontiers in Genetics1664-80212022-07-011310.3389/fgene.2022.856671856671A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell CarcinomaHuili Wu0Huili Wu1Huili Wu2Huili Wu3Xiao Zhao4Xiao Zhao5Xiao Zhao6Xiao Zhao7Tingting Zhu8Tingting Zhu9Tingting Zhu10Tingting Zhu11Di Rong12Di Rong13Di Rong14Di Rong15Ying Wang16Ying Wang17Ying Wang18Ying Wang19Diya Leng20Diya Leng21Diya Leng22Diya Leng23Daming Wu24Daming Wu25Daming Wu26Daming Wu27Department of Endodontics, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Oral and Maxillofacial Imaging, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, ChinaJiangsu Province Key Laboratory of Oral Diseases, Nanjing, ChinaJiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing, ChinaDepartment of Endodontics, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Oral and Maxillofacial Imaging, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, ChinaJiangsu Province Key Laboratory of Oral Diseases, Nanjing, ChinaJiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing, ChinaDepartment of Endodontics, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Oral and Maxillofacial Imaging, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, ChinaJiangsu Province Key Laboratory of Oral Diseases, Nanjing, ChinaJiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing, ChinaDepartment of Endodontics, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Oral and Maxillofacial Imaging, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, ChinaJiangsu Province Key Laboratory of Oral Diseases, Nanjing, ChinaJiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing, ChinaDepartment of Endodontics, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Oral and Maxillofacial Imaging, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, ChinaJiangsu Province Key Laboratory of Oral Diseases, Nanjing, ChinaJiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing, ChinaDepartment of Endodontics, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Oral and Maxillofacial Imaging, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, ChinaJiangsu Province Key Laboratory of Oral Diseases, Nanjing, ChinaJiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing, ChinaDepartment of Endodontics, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Oral and Maxillofacial Imaging, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, ChinaJiangsu Province Key Laboratory of Oral Diseases, Nanjing, ChinaJiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing, ChinaBackground: Here, we establish a prognostic signature based on glycosyltransferase-related genes (GTRGs) for head and neck squamous cell carcinoma (HNSCC) patients.Methods: The prognostic signature of GTRGs was constructed via univariate and multivariate Cox analyses after obtaining the expression patterns of GTRGs from the TCGA. A nomogram based on the signature and clinical parameters was established to predict the survival of each HNSCC patient. Potential mechanisms were explored through gene set enrichment analysis (GSEA) and immune cell infiltration, immune checkpoints, immunotherapy, and tumor mutational burden (TMB) analyses. The expression differences and prognostic efficacy of the signature were verified through the gene expression omnibus (GEO) and several online databases.Results: The prognostic signature was constructed based on five glycosyltransferases (PYGL, ALG3, EXT2, FUT2, and KDELC1) and validated in the GSE65858 dataset. The pathways enriched in the high- and low-risk groups were significantly different. The high-risk group had higher tumor purity; lower infiltration of immune cells, such as CD8+ T cells and Tregs; higher cancer-associated fibroblast (CAF) infiltration; lower immune function; and lower checkpoint expression. The signature can also be applied to distinguish whether patients benefit from immunotherapy. In addition, the high-risk group had a higher TMB and more gene mutations, including those in TP53, CSMD1, CDKN2A, and MUC17.Conclusion: We propose a prognostic signature based on glycosyltransferases for HNSCC patients that may provide potential targets and biomarkers for the precise treatment of HNSCC.https://www.frontiersin.org/articles/10.3389/fgene.2022.856671/fullglycosyltransferaseprognostic signaturehead and neck squamous cell carcinomaimmune cell infiltrationtumor mutational burden
spellingShingle Huili Wu
Huili Wu
Huili Wu
Huili Wu
Xiao Zhao
Xiao Zhao
Xiao Zhao
Xiao Zhao
Tingting Zhu
Tingting Zhu
Tingting Zhu
Tingting Zhu
Di Rong
Di Rong
Di Rong
Di Rong
Ying Wang
Ying Wang
Ying Wang
Ying Wang
Diya Leng
Diya Leng
Diya Leng
Diya Leng
Daming Wu
Daming Wu
Daming Wu
Daming Wu
A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
Frontiers in Genetics
glycosyltransferase
prognostic signature
head and neck squamous cell carcinoma
immune cell infiltration
tumor mutational burden
title A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
title_full A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
title_fullStr A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
title_full_unstemmed A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
title_short A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
title_sort glycosyltransferase related signature for predicting overall survival in head and neck squamous cell carcinoma
topic glycosyltransferase
prognostic signature
head and neck squamous cell carcinoma
immune cell infiltration
tumor mutational burden
url https://www.frontiersin.org/articles/10.3389/fgene.2022.856671/full
work_keys_str_mv AT huiliwu aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT huiliwu aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT huiliwu aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT huiliwu aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT xiaozhao aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT xiaozhao aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT xiaozhao aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT xiaozhao aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT tingtingzhu aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT tingtingzhu aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT tingtingzhu aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT tingtingzhu aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT dirong aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT dirong aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT dirong aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT dirong aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT yingwang aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT yingwang aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT yingwang aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT yingwang aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT diyaleng aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT diyaleng aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT diyaleng aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT diyaleng aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT damingwu aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT damingwu aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT damingwu aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT damingwu aglycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT huiliwu glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT huiliwu glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT huiliwu glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT huiliwu glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT xiaozhao glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT xiaozhao glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT xiaozhao glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT xiaozhao glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT tingtingzhu glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT tingtingzhu glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT tingtingzhu glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT tingtingzhu glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT dirong glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT dirong glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT dirong glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT dirong glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT yingwang glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT yingwang glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT yingwang glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT yingwang glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT diyaleng glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT diyaleng glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT diyaleng glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT diyaleng glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT damingwu glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT damingwu glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT damingwu glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma
AT damingwu glycosyltransferaserelatedsignatureforpredictingoverallsurvivalinheadandnecksquamouscellcarcinoma